nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Progesterone Congeners—Medroxyprogesterone Acetate—uterine cancer	0.391	1	CiPCiCtD
Etonogestrel—PGR—uterine cancer	0.103	0.613	CbGaD
Etonogestrel—ESR1—uterine cancer	0.0652	0.387	CbGaD
Etonogestrel—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0434	0.219	CbGbCtD
Etonogestrel—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0416	0.21	CbGbCtD
Etonogestrel—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0301	0.152	CbGbCtD
Etonogestrel—PGR—Progesterone—uterine cancer	0.0287	0.145	CbGbCtD
Etonogestrel—SHBG—Progesterone—uterine cancer	0.0276	0.139	CbGbCtD
Etonogestrel—Nandrolone decanoate—Progesterone—uterine cancer	0.0254	0.15	CrCrCtD
Etonogestrel—Nandrolone phenpropionate—Progesterone—uterine cancer	0.0254	0.15	CrCrCtD
Etonogestrel—Norgestimate—Progesterone—uterine cancer	0.0238	0.14	CrCrCtD
Etonogestrel—ESR1—Progesterone—uterine cancer	0.0199	0.101	CbGbCtD
Etonogestrel—Levonorgestrel—Progesterone—uterine cancer	0.0176	0.104	CrCrCtD
Etonogestrel—Danazol—Progesterone—uterine cancer	0.0162	0.0957	CrCrCtD
Etonogestrel—Norethindrone—Progesterone—uterine cancer	0.0141	0.0833	CrCrCtD
Etonogestrel—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0133	0.0784	CrCrCtD
Etonogestrel—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0118	0.0698	CrCrCtD
Etonogestrel—Methyltestosterone—Progesterone—uterine cancer	0.0116	0.0683	CrCrCtD
Etonogestrel—Testosterone—Progesterone—uterine cancer	0.0103	0.0608	CrCrCtD
Etonogestrel—PGR—corpus luteum—uterine cancer	0.0037	0.233	CbGeAlD
Etonogestrel—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.0156	CbGbCtD
Etonogestrel—CYP3A4—Progesterone—uterine cancer	0.00205	0.0103	CbGbCtD
Etonogestrel—SHBG—semen—uterine cancer	0.00193	0.121	CbGeAlD
Etonogestrel—PGR—oviduct—uterine cancer	0.00127	0.0799	CbGeAlD
Etonogestrel—ESR1—oviduct—uterine cancer	0.000995	0.0625	CbGeAlD
Etonogestrel—CYP3A4—Etoposide—uterine cancer	0.000916	0.00463	CbGbCtD
Etonogestrel—PGR—artery—uterine cancer	0.000842	0.0529	CbGeAlD
Etonogestrel—CYP3A4—Doxorubicin—uterine cancer	0.000625	0.00316	CbGbCtD
Etonogestrel—PGR—myometrium—uterine cancer	0.000407	0.0256	CbGeAlD
Etonogestrel—PGR—epithelium—uterine cancer	0.000319	0.0201	CbGeAlD
Etonogestrel—ESR1—myometrium—uterine cancer	0.000318	0.02	CbGeAlD
Etonogestrel—SHBG—endometrium—uterine cancer	0.000318	0.02	CbGeAlD
Etonogestrel—PGR—uterine cervix—uterine cancer	0.000317	0.0199	CbGeAlD
Etonogestrel—PGR—smooth muscle tissue—uterine cancer	0.000308	0.0193	CbGeAlD
Etonogestrel—PGR—decidua—uterine cancer	0.000302	0.019	CbGeAlD
Etonogestrel—SHBG—uterus—uterine cancer	0.000293	0.0184	CbGeAlD
Etonogestrel—PGR—endometrium—uterine cancer	0.000286	0.018	CbGeAlD
Etonogestrel—PGR—uterus—uterine cancer	0.000264	0.0166	CbGeAlD
Etonogestrel—SHBG—female reproductive system—uterine cancer	0.000263	0.0165	CbGeAlD
Etonogestrel—ESR1—epithelium—uterine cancer	0.00025	0.0157	CbGeAlD
Etonogestrel—ESR1—uterine cervix—uterine cancer	0.000248	0.0156	CbGeAlD
Etonogestrel—ESR1—smooth muscle tissue—uterine cancer	0.000241	0.0151	CbGeAlD
Etonogestrel—SHBG—female gonad—uterine cancer	0.00024	0.0151	CbGeAlD
Etonogestrel—SHBG—vagina—uterine cancer	0.000238	0.015	CbGeAlD
Etonogestrel—PGR—female reproductive system—uterine cancer	0.000237	0.0149	CbGeAlD
Etonogestrel—ESR1—decidua—uterine cancer	0.000236	0.0148	CbGeAlD
Etonogestrel—ESR1—renal system—uterine cancer	0.000232	0.0146	CbGeAlD
Etonogestrel—ESR1—endometrium—uterine cancer	0.000224	0.0141	CbGeAlD
Etonogestrel—PGR—female gonad—uterine cancer	0.000216	0.0136	CbGeAlD
Etonogestrel—PGR—vagina—uterine cancer	0.000215	0.0135	CbGeAlD
Etonogestrel—PGR—Ovarian Infertility Genes—MLH1—uterine cancer	0.000207	0.0346	CbGpPWpGaD
Etonogestrel—ESR1—uterus—uterine cancer	0.000206	0.013	CbGeAlD
Etonogestrel—ESR1—female reproductive system—uterine cancer	0.000186	0.0117	CbGeAlD
Etonogestrel—PGR—Ovarian Infertility Genes—ESR2—uterine cancer	0.000173	0.0289	CbGpPWpGaD
Etonogestrel—ESR1—female gonad—uterine cancer	0.000169	0.0106	CbGeAlD
Etonogestrel—ESR1—vagina—uterine cancer	0.000168	0.0105	CbGeAlD
Etonogestrel—PGR—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.000157	0.0262	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptors—ESR2—uterine cancer	0.000151	0.0252	CbGpPWpGaD
Etonogestrel—PGR—lymph node—uterine cancer	0.000139	0.00872	CbGeAlD
Etonogestrel—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000138	0.0231	CbGpPWpGaD
Etonogestrel—Norelgestromin—PGR—uterine cancer	0.000136	0.083	CrCbGaD
Etonogestrel—Desogestrel—PGR—uterine cancer	0.000131	0.0799	CrCbGaD
Etonogestrel—CYP3A4—renal system—uterine cancer	0.000129	0.00812	CbGeAlD
Etonogestrel—PGR—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000128	0.0215	CbGpPWpGaD
Etonogestrel—Norgestimate—PGR—uterine cancer	0.000122	0.0747	CrCbGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000119	0.0199	CbGpPWpGaD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	0.000117	0.0195	CbGpPWpGaD
Etonogestrel—Danazol—CCL2—uterine cancer	0.000112	0.0684	CrCbGaD
Etonogestrel—Quinestrol—ESR1—uterine cancer	0.00011	0.0674	CrCbGaD
Etonogestrel—ESR1—lymph node—uterine cancer	0.000109	0.00682	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—uterine cancer	0.000108	0.0181	CbGpPWpGaD
Etonogestrel—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000106	0.0178	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000106	0.0177	CbGpPWpGaD
Etonogestrel—CYP3A4—female reproductive system—uterine cancer	0.000104	0.00651	CbGeAlD
Etonogestrel—Nandrolone phenpropionate—CYP19A1—uterine cancer	0.000102	0.0622	CrCbGaD
Etonogestrel—ESR1—Nuclear Receptors—PGR—uterine cancer	0.0001	0.0168	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	9.93e-05	0.0166	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear signaling by ERBB4—PGR—uterine cancer	9.84e-05	0.0164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	9.58e-05	0.016	CbGpPWpGaD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—AKT1—uterine cancer	9.55e-05	0.0159	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptors—ESR1—uterine cancer	9.14e-05	0.0153	CbGpPWpGaD
Etonogestrel—PGR—Nuclear signaling by ERBB4—ESR1—uterine cancer	8.95e-05	0.015	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—ESR2—uterine cancer	8.84e-05	0.0148	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—YWHAE—uterine cancer	8.68e-05	0.0145	CbGpPWpGaD
Etonogestrel—Mestranol—ESR1—uterine cancer	8.34e-05	0.051	CrCbGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—ESR2—uterine cancer	8.32e-05	0.0139	CbGpPWpGaD
Etonogestrel—Desogestrel—ESR1—uterine cancer	8.24e-05	0.0504	CrCbGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	7.94e-05	0.0133	CbGpPWpGaD
Etonogestrel—Nandrolone decanoate—CYP19A1—uterine cancer	7.71e-05	0.0472	CrCbGaD
Etonogestrel—Norgestimate—ESR1—uterine cancer	7.71e-05	0.0472	CrCbGaD
Etonogestrel—Levonorgestrel—PGR—uterine cancer	7.48e-05	0.0457	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	7.31e-05	0.0122	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—STK11—uterine cancer	7.27e-05	0.0122	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	7.22e-05	0.0121	CbGpPWpGaD
Etonogestrel—PGR—Ovarian Infertility Genes—CDKN1B—uterine cancer	7.13e-05	0.0119	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	6.99e-05	0.0117	CbGpPWpGaD
Etonogestrel—Danazol—PGR—uterine cancer	6.81e-05	0.0417	CrCbGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	6.62e-05	0.0111	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	6.58e-05	0.011	CbGpPWpGaD
Etonogestrel—Ethinyl Estradiol—ESR2—uterine cancer	6.46e-05	0.0395	CrCbGaD
Etonogestrel—ESR1—Regulation of Telomerase—IRF1—uterine cancer	6.44e-05	0.0108	CbGpPWpGaD
Etonogestrel—Norethindrone—PGR—uterine cancer	6.06e-05	0.0371	CrCbGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	6.02e-05	0.0101	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	6.02e-05	0.0101	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	5.83e-05	0.00974	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	5.73e-05	0.00958	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	5.29e-05	0.00884	CbGpPWpGaD
Etonogestrel—Levonorgestrel—CYP19A1—uterine cancer	5.13e-05	0.0314	CrCbGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	4.81e-05	0.00803	CbGpPWpGaD
Etonogestrel—Levonorgestrel—ESR1—uterine cancer	4.72e-05	0.0289	CrCbGaD
Etonogestrel—Danazol—CYP19A1—uterine cancer	4.67e-05	0.0286	CrCbGaD
Etonogestrel—Testosterone—CYP11A1—uterine cancer	4.43e-05	0.0271	CrCbGaD
Etonogestrel—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	4.36e-05	0.00729	CbGpPWpGaD
Etonogestrel—Danazol—ESR1—uterine cancer	4.3e-05	0.0263	CrCbGaD
Etonogestrel—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	4.13e-05	0.00689	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	4.09e-05	0.00683	CbGpPWpGaD
Etonogestrel—Ethinyl Estradiol—ESR1—uterine cancer	3.98e-05	0.0243	CrCbGaD
Etonogestrel—Methyltestosterone—CYP19A1—uterine cancer	3.95e-05	0.0241	CrCbGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	3.93e-05	0.00656	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	3.9e-05	0.00651	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	3.8e-05	0.00635	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	3.59e-05	0.00601	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	3.59e-05	0.00599	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	3.54e-05	0.00591	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—FGFR2—uterine cancer	3.52e-05	0.00589	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PGR—uterine cancer	3.31e-05	0.00554	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	3.24e-05	0.00542	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PHF1—uterine cancer	3.17e-05	0.0053	CbGpPWpGaD
Etonogestrel—Oedema—Dactinomycin—uterine cancer	3.14e-05	0.000634	CcSEcCtD
Etonogestrel—Fluid retention—Doxorubicin—uterine cancer	3.13e-05	0.000633	CcSEcCtD
Etonogestrel—Urethral disorder—Etoposide—uterine cancer	3.13e-05	0.000633	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.13e-05	0.00523	CbGpPWpGaD
Etonogestrel—Infection—Dactinomycin—uterine cancer	3.12e-05	0.00063	CcSEcCtD
Etonogestrel—Vaginal infection—Doxorubicin—uterine cancer	3.12e-05	0.00063	CcSEcCtD
Etonogestrel—Abnormal vision—Epirubicin—uterine cancer	3.11e-05	0.000629	CcSEcCtD
Etonogestrel—Diarrhoea—Progesterone—uterine cancer	3.04e-05	0.000614	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—ESR1—uterine cancer	3.01e-05	0.00504	CbGpPWpGaD
Etonogestrel—Anorexia—Dactinomycin—uterine cancer	2.99e-05	0.000604	CcSEcCtD
Etonogestrel—Eye disorder—Etoposide—uterine cancer	2.99e-05	0.000604	CcSEcCtD
Etonogestrel—Bladder pain—Doxorubicin—uterine cancer	2.98e-05	0.000603	CcSEcCtD
Etonogestrel—Neoplasm—Doxorubicin—uterine cancer	2.98e-05	0.000603	CcSEcCtD
Etonogestrel—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	2.96e-05	0.000599	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	2.96e-05	0.00494	CbGpPWpGaD
Etonogestrel—Dizziness—Progesterone—uterine cancer	2.94e-05	0.000593	CcSEcCtD
Etonogestrel—Angiopathy—Etoposide—uterine cancer	2.9e-05	0.000586	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	2.9e-05	0.00484	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	2.89e-05	0.00483	CbGpPWpGaD
Etonogestrel—Immune system disorder—Etoposide—uterine cancer	2.89e-05	0.000583	CcSEcCtD
Etonogestrel—Asthenia—Medroxyprogesterone Acetate—uterine cancer	2.89e-05	0.000583	CcSEcCtD
Etonogestrel—Eczema—Epirubicin—uterine cancer	2.88e-05	0.000582	CcSEcCtD
Etonogestrel—Abnormal vision—Doxorubicin—uterine cancer	2.88e-05	0.000582	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dactinomycin—uterine cancer	2.86e-05	0.000578	CcSEcCtD
Etonogestrel—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	2.85e-05	0.00476	CbGpPWpGaD
Etonogestrel—Pruritus—Medroxyprogesterone Acetate—uterine cancer	2.85e-05	0.000575	CcSEcCtD
Etonogestrel—Alopecia—Etoposide—uterine cancer	2.82e-05	0.000571	CcSEcCtD
Etonogestrel—Vomiting—Progesterone—uterine cancer	2.82e-05	0.00057	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	2.82e-05	0.00471	CbGpPWpGaD
Etonogestrel—Rash—Progesterone—uterine cancer	2.8e-05	0.000566	CcSEcCtD
Etonogestrel—Dermatitis—Progesterone—uterine cancer	2.8e-05	0.000565	CcSEcCtD
Etonogestrel—Headache—Progesterone—uterine cancer	2.78e-05	0.000562	CcSEcCtD
Etonogestrel—Hot flush—Epirubicin—uterine cancer	2.77e-05	0.00056	CcSEcCtD
Etonogestrel—Increased appetite—Epirubicin—uterine cancer	2.76e-05	0.000557	CcSEcCtD
Etonogestrel—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	2.75e-05	0.000556	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.75e-05	0.00459	CbGpPWpGaD
Etonogestrel—Menopausal symptoms—Epirubicin—uterine cancer	2.74e-05	0.000555	CcSEcCtD
Etonogestrel—Decreased appetite—Dactinomycin—uterine cancer	2.73e-05	0.000551	CcSEcCtD
Etonogestrel—Fatigue—Dactinomycin—uterine cancer	2.7e-05	0.000547	CcSEcCtD
Etonogestrel—PGR—Gene Expression—CHD4—uterine cancer	2.7e-05	0.0045	CbGpPWpGaD
Etonogestrel—Back pain—Etoposide—uterine cancer	2.69e-05	0.000544	CcSEcCtD
Etonogestrel—Pain—Dactinomycin—uterine cancer	2.68e-05	0.000542	CcSEcCtD
Etonogestrel—Muscle spasms—Etoposide—uterine cancer	2.67e-05	0.000541	CcSEcCtD
Etonogestrel—Eczema—Doxorubicin—uterine cancer	2.67e-05	0.000539	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	2.66e-05	0.00445	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	2.66e-05	0.00445	CbGpPWpGaD
Etonogestrel—Dizziness—Medroxyprogesterone Acetate—uterine cancer	2.66e-05	0.000538	CcSEcCtD
Etonogestrel—Nausea—Progesterone—uterine cancer	2.64e-05	0.000533	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	2.63e-05	0.00439	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.62e-05	0.00438	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.6e-05	0.00435	CbGpPWpGaD
Etonogestrel—Pain in extremity—Epirubicin—uterine cancer	2.59e-05	0.000523	CcSEcCtD
Etonogestrel—Feeling abnormal—Dactinomycin—uterine cancer	2.59e-05	0.000523	CcSEcCtD
Etonogestrel—Ill-defined disorder—Etoposide—uterine cancer	2.58e-05	0.000522	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.57e-05	0.00429	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Dactinomycin—uterine cancer	2.57e-05	0.000519	CcSEcCtD
Etonogestrel—Hot flush—Doxorubicin—uterine cancer	2.56e-05	0.000518	CcSEcCtD
Etonogestrel—Vomiting—Medroxyprogesterone Acetate—uterine cancer	2.56e-05	0.000517	CcSEcCtD
Etonogestrel—Increased appetite—Doxorubicin—uterine cancer	2.55e-05	0.000515	CcSEcCtD
Etonogestrel—Migraine—Epirubicin—uterine cancer	2.55e-05	0.000515	CcSEcCtD
Etonogestrel—Affect lability—Epirubicin—uterine cancer	2.55e-05	0.000515	CcSEcCtD
Etonogestrel—Menopausal symptoms—Doxorubicin—uterine cancer	2.54e-05	0.000513	CcSEcCtD
Etonogestrel—Rash—Medroxyprogesterone Acetate—uterine cancer	2.54e-05	0.000513	CcSEcCtD
Etonogestrel—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	2.53e-05	0.000512	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	2.53e-05	0.00422	CbGpPWpGaD
Etonogestrel—Headache—Medroxyprogesterone Acetate—uterine cancer	2.52e-05	0.000509	CcSEcCtD
Etonogestrel—Malaise—Etoposide—uterine cancer	2.51e-05	0.000507	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—uterine cancer	2.48e-05	0.000501	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—uterine cancer	2.48e-05	0.000501	CcSEcCtD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	2.47e-05	0.00412	CbGpPWpGaD
Etonogestrel—Mood swings—Epirubicin—uterine cancer	2.45e-05	0.000496	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	2.45e-05	0.00409	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	2.44e-05	0.00407	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.43e-05	0.00406	CbGpPWpGaD
Etonogestrel—Cough—Etoposide—uterine cancer	2.43e-05	0.000491	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	2.43e-05	0.00405	CbGpPWpGaD
Etonogestrel—Convulsion—Etoposide—uterine cancer	2.41e-05	0.000487	CcSEcCtD
Etonogestrel—Hypertension—Etoposide—uterine cancer	2.4e-05	0.000486	CcSEcCtD
Etonogestrel—Pain in extremity—Doxorubicin—uterine cancer	2.4e-05	0.000484	CcSEcCtD
Etonogestrel—Nausea—Medroxyprogesterone Acetate—uterine cancer	2.39e-05	0.000483	CcSEcCtD
Etonogestrel—Affect lability—Doxorubicin—uterine cancer	2.36e-05	0.000477	CcSEcCtD
Etonogestrel—Migraine—Doxorubicin—uterine cancer	2.36e-05	0.000477	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	2.35e-05	0.000475	CcSEcCtD
Etonogestrel—Discomfort—Etoposide—uterine cancer	2.34e-05	0.000473	CcSEcCtD
Etonogestrel—Breast disorder—Epirubicin—uterine cancer	2.34e-05	0.000473	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—uterine cancer	2.31e-05	0.000467	CcSEcCtD
Etonogestrel—Gastritis—Epirubicin—uterine cancer	2.29e-05	0.000463	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	2.29e-05	0.00383	CbGpPWpGaD
Etonogestrel—Testosterone—CYP19A1—uterine cancer	2.29e-05	0.014	CrCbGaD
Etonogestrel—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	2.29e-05	0.00382	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	2.29e-05	0.00382	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Etoposide—uterine cancer	2.27e-05	0.000459	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—uterine cancer	2.27e-05	0.000459	CcSEcCtD
Etonogestrel—PGR—Gene Expression—SUZ12—uterine cancer	2.26e-05	0.00377	CbGpPWpGaD
Etonogestrel—Infection—Etoposide—uterine cancer	2.26e-05	0.000456	CcSEcCtD
Etonogestrel—Abdominal distension—Epirubicin—uterine cancer	2.25e-05	0.000455	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	2.25e-05	0.00376	CbGpPWpGaD
Etonogestrel—Asthenia—Dactinomycin—uterine cancer	2.25e-05	0.000455	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	2.25e-05	0.00375	CbGpPWpGaD
Etonogestrel—Asthma—Epirubicin—uterine cancer	2.24e-05	0.000452	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	2.24e-05	0.00374	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	2.23e-05	0.00372	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ERBB2—uterine cancer	2.21e-05	0.0037	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.21e-05	0.0037	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.21e-05	0.00369	CbGpPWpGaD
Etonogestrel—Skin disorder—Etoposide—uterine cancer	2.21e-05	0.000446	CcSEcCtD
Etonogestrel—Breast disorder—Doxorubicin—uterine cancer	2.17e-05	0.000438	CcSEcCtD
Etonogestrel—Anorexia—Etoposide—uterine cancer	2.16e-05	0.000437	CcSEcCtD
Etonogestrel—Bronchitis—Epirubicin—uterine cancer	2.15e-05	0.000435	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—uterine cancer	2.15e-05	0.000434	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—uterine cancer	2.12e-05	0.000429	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	2.11e-05	0.00353	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	2.11e-05	0.00352	CbGpPWpGaD
Etonogestrel—Dysuria—Epirubicin—uterine cancer	2.09e-05	0.000423	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—uterine cancer	2.08e-05	0.000421	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Epirubicin—uterine cancer	2.08e-05	0.00042	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—TP53—uterine cancer	2.08e-05	0.00347	CbGpPWpGaD
Etonogestrel—Asthma—Doxorubicin—uterine cancer	2.07e-05	0.000419	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	2.07e-05	0.00345	CbGpPWpGaD
Etonogestrel—Pollakiuria—Epirubicin—uterine cancer	2.07e-05	0.000418	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	2.06e-05	0.00344	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	2.06e-05	0.00344	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR2—uterine cancer	2.06e-05	0.00344	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1B—uterine cancer	2.05e-05	0.00342	CbGpPWpGaD
Etonogestrel—Paraesthesia—Etoposide—uterine cancer	2.04e-05	0.000412	CcSEcCtD
Etonogestrel—Weight increased—Epirubicin—uterine cancer	2.04e-05	0.000412	CcSEcCtD
Etonogestrel—Weight decreased—Epirubicin—uterine cancer	2.03e-05	0.000409	CcSEcCtD
Etonogestrel—Somnolence—Etoposide—uterine cancer	2.02e-05	0.000408	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	2e-05	0.00334	CbGpPWpGaD
Etonogestrel—Infestation—Epirubicin—uterine cancer	2e-05	0.000403	CcSEcCtD
Etonogestrel—Infestation NOS—Epirubicin—uterine cancer	2e-05	0.000403	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—uterine cancer	1.99e-05	0.000403	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—uterine cancer	1.99e-05	0.000403	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—uterine cancer	1.98e-05	0.0004	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.98e-05	0.0033	CbGpPWpGaD
Etonogestrel—Decreased appetite—Etoposide—uterine cancer	1.97e-05	0.000399	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—EP300—uterine cancer	1.96e-05	0.00328	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Etoposide—uterine cancer	1.96e-05	0.000396	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—uterine cancer	1.96e-05	0.000396	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Epirubicin—uterine cancer	1.96e-05	0.000395	CcSEcCtD
Etonogestrel—Constipation—Etoposide—uterine cancer	1.94e-05	0.000392	CcSEcCtD
Etonogestrel—Pain—Etoposide—uterine cancer	1.94e-05	0.000392	CcSEcCtD
Etonogestrel—Urinary tract infection—Epirubicin—uterine cancer	1.94e-05	0.000392	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—uterine cancer	1.94e-05	0.000391	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—uterine cancer	1.92e-05	0.000389	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—uterine cancer	1.91e-05	0.000387	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PTEN—uterine cancer	1.89e-05	0.00315	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.89e-05	0.00315	CbGpPWpGaD
Etonogestrel—Weight increased—Doxorubicin—uterine cancer	1.88e-05	0.000381	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.88e-05	0.00314	CbGpPWpGaD
Etonogestrel—Weight decreased—Doxorubicin—uterine cancer	1.87e-05	0.000379	CcSEcCtD
Etonogestrel—Sinusitis—Epirubicin—uterine cancer	1.87e-05	0.000378	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—uterine cancer	1.87e-05	0.000378	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—uterine cancer	1.86e-05	0.000377	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—PHF1—uterine cancer	1.86e-05	0.00311	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Etoposide—uterine cancer	1.86e-05	0.000375	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—uterine cancer	1.85e-05	0.000373	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—uterine cancer	1.85e-05	0.000373	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	1.82e-05	0.00304	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.82e-05	0.00303	CbGpPWpGaD
Etonogestrel—Neuropathy peripheral—Doxorubicin—uterine cancer	1.81e-05	0.000366	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—uterine cancer	1.8e-05	0.000365	CcSEcCtD
Etonogestrel—Haemoglobin—Epirubicin—uterine cancer	1.8e-05	0.000364	CcSEcCtD
Etonogestrel—Rhinitis—Epirubicin—uterine cancer	1.8e-05	0.000363	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—uterine cancer	1.8e-05	0.000363	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—uterine cancer	1.8e-05	0.000363	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—uterine cancer	1.79e-05	0.000363	CcSEcCtD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.79e-05	0.00299	CbGpPWpGaD
Etonogestrel—Haemorrhage—Epirubicin—uterine cancer	1.79e-05	0.000362	CcSEcCtD
Etonogestrel—Hypoaesthesia—Epirubicin—uterine cancer	1.78e-05	0.00036	CcSEcCtD
Etonogestrel—Pharyngitis—Epirubicin—uterine cancer	1.78e-05	0.000359	CcSEcCtD
Etonogestrel—Urinary tract disorder—Epirubicin—uterine cancer	1.77e-05	0.000358	CcSEcCtD
Etonogestrel—Connective tissue disorder—Epirubicin—uterine cancer	1.76e-05	0.000356	CcSEcCtD
Etonogestrel—Urethral disorder—Epirubicin—uterine cancer	1.76e-05	0.000355	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.75e-05	0.00293	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.75e-05	0.00292	CbGpPWpGaD
Etonogestrel—Sinusitis—Doxorubicin—uterine cancer	1.73e-05	0.00035	CcSEcCtD
Etonogestrel—Visual impairment—Epirubicin—uterine cancer	1.73e-05	0.000349	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—NRAS—uterine cancer	1.68e-05	0.00281	CbGpPWpGaD
Etonogestrel—Eye disorder—Epirubicin—uterine cancer	1.67e-05	0.000338	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.67e-05	0.0028	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Etoposide—uterine cancer	1.67e-05	0.000338	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—uterine cancer	1.67e-05	0.000337	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—uterine cancer	1.66e-05	0.000336	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—uterine cancer	1.66e-05	0.000335	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—uterine cancer	1.65e-05	0.000333	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—uterine cancer	1.65e-05	0.000333	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—uterine cancer	1.64e-05	0.000331	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—uterine cancer	1.63e-05	0.000329	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—uterine cancer	1.63e-05	0.000329	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—uterine cancer	1.63e-05	0.000329	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—uterine cancer	1.63e-05	0.000328	CcSEcCtD
Etonogestrel—Immune system disorder—Epirubicin—uterine cancer	1.62e-05	0.000327	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—uterine cancer	1.61e-05	0.000325	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—uterine cancer	1.6e-05	0.000323	CcSEcCtD
Etonogestrel—Alopecia—Epirubicin—uterine cancer	1.58e-05	0.00032	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—CHD4—uterine cancer	1.58e-05	0.00264	CbGpPWpGaD
Etonogestrel—Mental disorder—Epirubicin—uterine cancer	1.57e-05	0.000317	CcSEcCtD
Etonogestrel—Erythema—Epirubicin—uterine cancer	1.56e-05	0.000315	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—uterine cancer	1.56e-05	0.000315	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—uterine cancer	1.55e-05	0.000314	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—uterine cancer	1.55e-05	0.000313	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.55e-05	0.00259	CbGpPWpGaD
Etonogestrel—Flatulence—Epirubicin—uterine cancer	1.54e-05	0.000311	CcSEcCtD
Etonogestrel—Tension—Epirubicin—uterine cancer	1.53e-05	0.000309	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	1.53e-05	0.00255	CbGpPWpGaD
Etonogestrel—Nervousness—Epirubicin—uterine cancer	1.51e-05	0.000306	CcSEcCtD
Etonogestrel—Back pain—Epirubicin—uterine cancer	1.51e-05	0.000305	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—uterine cancer	1.5e-05	0.000304	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—uterine cancer	1.5e-05	0.000303	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—uterine cancer	1.5e-05	0.000303	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—uterine cancer	1.5e-05	0.000303	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.47e-05	0.00246	CbGpPWpGaD
Etonogestrel—Alopecia—Doxorubicin—uterine cancer	1.46e-05	0.000296	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—uterine cancer	1.45e-05	0.000294	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—uterine cancer	1.45e-05	0.00242	CbGpPWpGaD
Etonogestrel—Ill-defined disorder—Epirubicin—uterine cancer	1.45e-05	0.000292	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—uterine cancer	1.44e-05	0.000292	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—uterine cancer	1.44e-05	0.000292	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—uterine cancer	1.44e-05	0.000292	CcSEcCtD
Etonogestrel—Rash—Etoposide—uterine cancer	1.43e-05	0.000289	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—uterine cancer	1.43e-05	0.000289	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—AKR1B10—uterine cancer	1.43e-05	0.00239	CbGpPWpGaD
Etonogestrel—Headache—Etoposide—uterine cancer	1.42e-05	0.000288	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—uterine cancer	1.42e-05	0.000287	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—uterine cancer	1.42e-05	0.000286	CcSEcCtD
Etonogestrel—Malaise—Epirubicin—uterine cancer	1.41e-05	0.000284	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—uterine cancer	1.41e-05	0.00235	CbGpPWpGaD
Etonogestrel—Nervousness—Doxorubicin—uterine cancer	1.4e-05	0.000283	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—uterine cancer	1.4e-05	0.000282	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—uterine cancer	1.39e-05	0.00028	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—PGR—uterine cancer	1.37e-05	0.00229	CbGpPWpGaD
Etonogestrel—Cough—Epirubicin—uterine cancer	1.36e-05	0.000275	CcSEcCtD
Etonogestrel—Convulsion—Epirubicin—uterine cancer	1.35e-05	0.000273	CcSEcCtD
Etonogestrel—Nausea—Etoposide—uterine cancer	1.35e-05	0.000273	CcSEcCtD
Etonogestrel—Hypertension—Epirubicin—uterine cancer	1.35e-05	0.000272	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—uterine cancer	1.34e-05	0.000271	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	1.33e-05	0.00222	CbGpPWpGaD
Etonogestrel—Myalgia—Epirubicin—uterine cancer	1.33e-05	0.000268	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—uterine cancer	1.33e-05	0.000268	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—SUZ12—uterine cancer	1.33e-05	0.00221	CbGpPWpGaD
Etonogestrel—Anxiety—Epirubicin—uterine cancer	1.32e-05	0.000267	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.32e-05	0.000267	CcSEcCtD
Etonogestrel—Discomfort—Epirubicin—uterine cancer	1.31e-05	0.000265	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—uterine cancer	1.3e-05	0.000263	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	1.3e-05	0.00217	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.29e-05	0.00215	CbGpPWpGaD
Etonogestrel—Oedema—Epirubicin—uterine cancer	1.27e-05	0.000257	CcSEcCtD
Etonogestrel—Anaphylactic shock—Epirubicin—uterine cancer	1.27e-05	0.000257	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—uterine cancer	1.27e-05	0.00212	CbGpPWpGaD
Etonogestrel—Infection—Epirubicin—uterine cancer	1.26e-05	0.000256	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—uterine cancer	1.26e-05	0.000255	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—uterine cancer	1.25e-05	0.000253	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—uterine cancer	1.25e-05	0.000252	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—ESR1—uterine cancer	1.25e-05	0.00208	CbGpPWpGaD
Etonogestrel—Hypertension—Doxorubicin—uterine cancer	1.25e-05	0.000252	CcSEcCtD
Etonogestrel—Skin disorder—Epirubicin—uterine cancer	1.24e-05	0.00025	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—uterine cancer	1.23e-05	0.00206	CbGpPWpGaD
Etonogestrel—Arthralgia—Doxorubicin—uterine cancer	1.23e-05	0.000248	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—uterine cancer	1.23e-05	0.000248	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—uterine cancer	1.22e-05	0.000247	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	1.22e-05	0.000247	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—uterine cancer	1.21e-05	0.00203	CbGpPWpGaD
Etonogestrel—Discomfort—Doxorubicin—uterine cancer	1.21e-05	0.000245	CcSEcCtD
Etonogestrel—Anorexia—Epirubicin—uterine cancer	1.21e-05	0.000245	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	1.21e-05	0.00202	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	1.2e-05	0.00201	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RNF43—uterine cancer	1.18e-05	0.00198	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Doxorubicin—uterine cancer	1.18e-05	0.000238	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—uterine cancer	1.18e-05	0.000238	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—uterine cancer	1.17e-05	0.000236	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.16e-05	0.000234	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—uterine cancer	1.15e-05	0.000233	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—uterine cancer	1.15e-05	0.000233	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—uterine cancer	1.14e-05	0.000231	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—uterine cancer	1.14e-05	0.000231	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.14e-05	0.00191	CbGpPWpGaD
Etonogestrel—Somnolence—Epirubicin—uterine cancer	1.13e-05	0.000229	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.13e-05	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—uterine cancer	1.12e-05	0.00188	CbGpPWpGaD
Etonogestrel—Anorexia—Doxorubicin—uterine cancer	1.12e-05	0.000227	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—uterine cancer	1.12e-05	0.000226	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.11e-05	0.00186	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PTEN—uterine cancer	1.11e-05	0.00185	CbGpPWpGaD
Etonogestrel—Decreased appetite—Epirubicin—uterine cancer	1.11e-05	0.000224	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Epirubicin—uterine cancer	1.1e-05	0.000222	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—uterine cancer	1.1e-05	0.000222	CcSEcCtD
Etonogestrel—Pain—Epirubicin—uterine cancer	1.09e-05	0.00022	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—uterine cancer	1.09e-05	0.00022	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—uterine cancer	1.09e-05	0.00182	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INHBA—uterine cancer	1.08e-05	0.00181	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.08e-05	0.00181	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.07e-05	0.000217	CcSEcCtD
Etonogestrel—PGR—Gene Expression—EZH2—uterine cancer	1.07e-05	0.00178	CbGpPWpGaD
Etonogestrel—Insomnia—Doxorubicin—uterine cancer	1.07e-05	0.000215	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.06e-05	0.00178	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.06e-05	0.00177	CbGpPWpGaD
Etonogestrel—Paraesthesia—Doxorubicin—uterine cancer	1.06e-05	0.000214	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.06e-05	0.00176	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Epirubicin—uterine cancer	1.05e-05	0.000212	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.05e-05	0.00175	CbGpPWpGaD
Etonogestrel—Somnolence—Doxorubicin—uterine cancer	1.05e-05	0.000212	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—uterine cancer	1.04e-05	0.00021	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—uterine cancer	1.04e-05	0.00021	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—uterine cancer	1.02e-05	0.000207	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.02e-05	0.000206	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—uterine cancer	1.02e-05	0.000205	CcSEcCtD
Etonogestrel—Urticaria—Epirubicin—uterine cancer	1.01e-05	0.000204	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—uterine cancer	1.01e-05	0.000204	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—uterine cancer	1.01e-05	0.000204	CcSEcCtD
Etonogestrel—Abdominal pain—Epirubicin—uterine cancer	1.01e-05	0.000203	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—uterine cancer	1.01e-05	0.000203	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.01e-05	0.00168	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1e-05	0.00167	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR2—uterine cancer	9.9e-06	0.00165	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	9.9e-06	0.00165	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—NRAS—uterine cancer	9.88e-06	0.00165	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	9.83e-06	0.00164	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKR1C1—uterine cancer	9.75e-06	0.00163	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Doxorubicin—uterine cancer	9.71e-06	0.000196	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—uterine cancer	9.63e-06	0.000195	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.46e-06	0.00158	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Epirubicin—uterine cancer	9.38e-06	0.00019	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—uterine cancer	9.36e-06	0.000189	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—uterine cancer	9.31e-06	0.000188	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—uterine cancer	9.31e-06	0.000188	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.22e-06	0.00154	CbGpPWpGaD
Etonogestrel—Asthenia—Epirubicin—uterine cancer	9.13e-06	0.000185	CcSEcCtD
Etonogestrel—Pruritus—Epirubicin—uterine cancer	9.01e-06	0.000182	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	8.97e-06	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.8e-06	0.00147	CbGpPWpGaD
Etonogestrel—Diarrhoea—Epirubicin—uterine cancer	8.71e-06	0.000176	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—uterine cancer	8.68e-06	0.000175	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	8.55e-06	0.00143	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—uterine cancer	8.5e-06	0.00142	CbGpPWpGaD
Etonogestrel—Asthenia—Doxorubicin—uterine cancer	8.45e-06	0.000171	CcSEcCtD
Etonogestrel—Dizziness—Epirubicin—uterine cancer	8.42e-06	0.00017	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—AKR1B10—uterine cancer	8.38e-06	0.0014	CbGpPWpGaD
Etonogestrel—Pruritus—Doxorubicin—uterine cancer	8.33e-06	0.000168	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.33e-06	0.00139	CbGpPWpGaD
Etonogestrel—Vomiting—Epirubicin—uterine cancer	8.09e-06	0.000164	CcSEcCtD
Etonogestrel—PGR—Gene Expression—CDKN2B—uterine cancer	8.06e-06	0.00135	CbGpPWpGaD
Etonogestrel—Diarrhoea—Doxorubicin—uterine cancer	8.06e-06	0.000163	CcSEcCtD
Etonogestrel—Rash—Epirubicin—uterine cancer	8.03e-06	0.000162	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—uterine cancer	8.02e-06	0.000162	CcSEcCtD
Etonogestrel—Headache—Epirubicin—uterine cancer	7.97e-06	0.000161	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	7.82e-06	0.00131	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	7.81e-06	0.00131	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—uterine cancer	7.79e-06	0.000157	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	7.71e-06	0.00129	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	7.6e-06	0.00127	CbGpPWpGaD
Etonogestrel—Nausea—Epirubicin—uterine cancer	7.56e-06	0.000153	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—AKR1C3—uterine cancer	7.5e-06	0.00125	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—uterine cancer	7.49e-06	0.000151	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—uterine cancer	7.43e-06	0.00015	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—uterine cancer	7.42e-06	0.00015	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—uterine cancer	7.38e-06	0.000149	CcSEcCtD
Etonogestrel—PGR—Gene Expression—SMAD3—uterine cancer	7.36e-06	0.00123	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—uterine cancer	7.23e-06	0.00121	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.08e-06	0.00118	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—uterine cancer	7e-06	0.000141	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—YWHAE—uterine cancer	6.98e-06	0.00117	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RNF43—uterine cancer	6.95e-06	0.00116	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FBXW7—uterine cancer	6.69e-06	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PGR—uterine cancer	6.6e-06	0.0011	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.51e-06	0.00109	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	6.42e-06	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—uterine cancer	6.38e-06	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INHBA—uterine cancer	6.35e-06	0.00106	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.3e-06	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—EZH2—uterine cancer	6.27e-06	0.00105	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR1—uterine cancer	6.01e-06	0.001	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STK11—uterine cancer	5.85e-06	0.000977	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ESR2—uterine cancer	5.81e-06	0.000971	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKR1C1—uterine cancer	5.72e-06	0.000956	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SOCS3—uterine cancer	5.47e-06	0.000915	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.32e-06	0.000888	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—uterine cancer	5.24e-06	0.000876	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1R—uterine cancer	5.09e-06	0.00085	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SMAD3—uterine cancer	4.79e-06	0.000799	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—uterine cancer	4.73e-06	0.00079	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR2—uterine cancer	4.56e-06	0.000763	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKR1C3—uterine cancer	4.4e-06	0.000736	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SMAD3—uterine cancer	4.32e-06	0.000722	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PGR—uterine cancer	4.29e-06	0.000717	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.2e-06	0.000702	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.2e-06	0.000702	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—YWHAE—uterine cancer	4.09e-06	0.000684	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FBXW7—uterine cancer	3.93e-06	0.000656	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ESR1—uterine cancer	3.9e-06	0.000652	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL2—uterine cancer	3.44e-06	0.000574	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STK11—uterine cancer	3.43e-06	0.000573	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SOCS3—uterine cancer	3.21e-06	0.000537	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—uterine cancer	3.08e-06	0.000514	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—STAR—uterine cancer	3.04e-06	0.000508	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.04e-06	0.000508	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1R—uterine cancer	2.99e-06	0.000499	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—uterine cancer	2.87e-06	0.000479	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMAD3—uterine cancer	2.81e-06	0.000469	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—uterine cancer	2.72e-06	0.000454	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR2—uterine cancer	2.68e-06	0.000448	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1B—uterine cancer	2.65e-06	0.000443	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—uterine cancer	2.51e-06	0.000419	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—uterine cancer	2.44e-06	0.000408	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—POLD1—uterine cancer	2.38e-06	0.000398	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EP300—uterine cancer	2.33e-06	0.000389	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.23e-06	0.000373	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—uterine cancer	2.21e-06	0.000369	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—uterine cancer	2.18e-06	0.000364	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—uterine cancer	2.17e-06	0.000362	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL2—uterine cancer	2.02e-06	0.000337	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RRM2—uterine cancer	1.99e-06	0.000332	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—DCN—uterine cancer	1.93e-06	0.000322	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—uterine cancer	1.88e-06	0.000314	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.82e-06	0.000304	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—uterine cancer	1.72e-06	0.000288	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.72e-06	0.000287	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—uterine cancer	1.68e-06	0.000281	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—uterine cancer	1.67e-06	0.000279	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—uterine cancer	1.6e-06	0.000267	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—uterine cancer	1.6e-06	0.000267	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1B—uterine cancer	1.56e-06	0.00026	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—uterine cancer	1.47e-06	0.000246	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—uterine cancer	1.43e-06	0.00024	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—uterine cancer	1.41e-06	0.000235	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EP300—uterine cancer	1.37e-06	0.000229	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—STK11—uterine cancer	1.34e-06	0.000223	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.34e-06	0.000223	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—uterine cancer	1.3e-06	0.000216	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—uterine cancer	1.28e-06	0.000214	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—uterine cancer	1.27e-06	0.000212	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—uterine cancer	1.1e-06	0.000184	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—uterine cancer	1.01e-06	0.000169	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—uterine cancer	1.01e-06	0.000168	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—uterine cancer	9.79e-07	0.000164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—uterine cancer	9.36e-07	0.000156	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—uterine cancer	8.27e-07	0.000138	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—uterine cancer	5.59e-07	9.34e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EP300—uterine cancer	5.33e-07	8.91e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.95e-07	6.59e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—uterine cancer	3.22e-07	5.38e-05	CbGpPWpGaD
